This clinical trial is focused on studying Herpes Simplex Virus Encephalitis, a serious brain infection caused by the herpes simplex virus. The study is investigating the use of Dexamethasone, a medication that is given as an oral solution, to see if it can help improve brain function and recovery in patients affected by this condition. The purpose of the study is to determine if using this medication can lead to better outcomes in terms of memory and overall brain health six months after treatment.

Participants in the study will receive either Dexamethasone or a placebo, in addition to the standard treatment for the infection. The study will follow patients over a period of time to assess their recovery and brain function. This includes checking memory, processing speed, and other cognitive abilities at different intervals, such as six months and eighteen months after starting the treatment. The study will also look at other health outcomes, like the occurrence of seizures, time spent in the hospital, and overall survival.

Throughout the study, various tests will be conducted to monitor the patients’ progress. These tests will include assessments of memory and cognitive function, as well as evaluations of anxiety and depression. Additionally, the study will measure the quality of life and health status of participants at different points in time. The goal is to gather comprehensive information on how Dexamethasone affects recovery from Herpes Simplex Virus Encephalitis and to determine if it can be a beneficial addition to the current treatment options.